BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced,…
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical…
MADISON, Wis., Oct. 10, 2023 (GLOBE NEWSWIRE) — Stem Pharm, Inc., a drug discovery platform…